Cargando…
The Function of Transthyretin Complexes with Metallothionein in Alzheimer’s Disease
Alzheimer’s disease (AD) is one of the most frequently diagnosed types of dementia in the elderly. An important pathological feature in AD is the aggregation and deposition of the β-amyloid (Aβ) in extracellular plaques. Transthyretin (TTR) can cleave Aβ, resulting in the formation of short peptides...
Autores principales: | Zaręba, Natalia, Kepinska, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730073/ https://www.ncbi.nlm.nih.gov/pubmed/33256250 http://dx.doi.org/10.3390/ijms21239003 |
Ejemplares similares
-
The Impact of Fullerenes as Doxorubicin Nano-Transporters on Metallothionein and Superoxide Dismutase Status in MCF-10A Cells
por: Zaręba, Natalia, et al.
Publicado: (2022) -
Transthyretin and the brain re-visited: Is neuronal synthesis of transthyretin protective in Alzheimer's disease?
por: Li, Xinyi, et al.
Publicado: (2011) -
The Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases
por: Paluszkiewicz, Patrycja, et al.
Publicado: (2021) -
Metallothionein and Superoxide Dismutase—Antioxidative Protein Status in Fullerene-Doxorubicin Delivery to MCF-7 Human Breast Cancer Cells
por: Kepinska, Marta, et al.
Publicado: (2018) -
Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer’s Disease?
por: Saponaro, Federica, et al.
Publicado: (2020)